Advisors and Collaborators

Zhi-ren Liu, PhD
Dr. Liu is professor in Biology Department at Georgia State University. Currently, his laboratory is involved in studying the effects of anti-cancer drug treatments on tumor growth and clinical outcomes. He and his group have designed and generated various disease models for MRI including liver fibrosis, hepatocellular carcinoma, lung cancers, pancreatic cancers and other liver metastases.

Andrew Wang
Dr. Wang is the president and founder of Ocean Nanotech. He has been working on the development of the new MRI contrast agent for many years. He is experienced in starting and running small businesses focusing on the field of molecular imaging contrast agents, He has previously developed nanoparticle-based molecular imaging contrast agents including MRI, optical and CT contrast agents, transferring them from the research lab into current preclinical applications with more than 1000 customers worldwide.

Hans Grossniklaus, MD, MBA
Dr. Grossniklaus is a clinical scientist who directs an ocular oncology laboratory. He will assist with animal model preparation, pathological evaluation of tissue, and correlation of pathology changes with MRI images. His group will advise and consult on experimental design including animal experiments, cell lines, interpretation of results, and preparation of manuscripts. He will provide clinical/experimental pathology and oncology expertise including correlation of MRI images with the histology of metastatic tumors.

Shanping Yu, MD, PhD
Dr. Yu is a professor in the Department of Anesthesiology and the Department of Hematology/Oncology in Emory University. He will provide non-human primate models for toxicity, immunogenicity and PK/PD studies for monkey imaging at Yerkes Primate center. Dr. Yu has an appointment with Emory University and with the Atlanta Veterans Administration Health Center (VAMC).

Pardeep Mittal
Dr. Mittal is Director of MRI Body Imaging at Emory University. His research experience involves utilizing advanced MR imaging techniques, including dynamic contrast-enhanced perfusion, MR spectroscopy (MRS), and diffusion tensor imaging (DTI) (including skewness and kurtosis), to study patients with liver cancer. He has extensive experience in MRI results analysis especially in liver cancers, prostate cancers and liver metastasis from other origins.

Brad Farris
Dr. Farris is Associate Professor at Emory University School of Medicine. He has investigated human liver diseases with immunohistochemistry and whole slide imaging (WSI). His work also investigated the molecular alterations that occur after interventional radiology treatment of liver diseases. He also has interpreted the pathology of animal models of liver fibrosis.